Efficacy and Safety of Alogliptin Used in Combination With Sulfonylurea in Participants With Type 2 Diabetes in Japan

NCT01318083 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

312

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Alogliptin and glimepiride
DRUG: Alogliptin and glimepiride
DRUG: Glimepiride

Sponsor

Takeda